Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Document Type
Journal Article
Publication Date
7-28-2016
Student Program
MD
Journal
New England Journal of Medicine
Volume
375
Issue
4
Inclusive Pages
311-22
DOI
10.1056/NEJMoa1603827
Keywords
Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Hypoglycemic Agents; Liraglutide; Male; Middle Aged; Myocardial Infarction; Stroke; Treatment Outcome
APA Citation
Marso, S., Daniels, G., Brown-Frandsen, K., Kristensen, P., Mann, J., Nauck, M., Nissen, S., Pocock, S., Poulter, N., Ravn, L., Steinberg, W., Stockner, M., Zinman, B., Bergenstal, R., Buse, J., & Sood, A. (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.. New England Journal of Medicine, 375 (4). http://dx.doi.org/10.1056/NEJMoa1603827
Peer Reviewed
1
